YBX1 orchestrates LDHA-mediated metabolic reprogramming and NF-κB activation to drive clear cell renal cell carcinoma progression
Abstract Renal cell carcinoma (RCC) is sometimes referred to as a “metabolic disease”, as nearly all types of RCC are associated with the reprogramming of glucose and lipid metabolism. Y-box binding protein 1 (YBX1) plays a crucial regulatory role in the development and progression of various cancer...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Nature Publishing Group
2026-01-01
|
| Schriftenreihe: | Cell Death and Disease |
| Online-Zugang: | https://doi.org/10.1038/s41419-025-08261-0 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
